AON — AI Stock Forecast & Price Targets

Published 9/4/2026 · A free sample of K3vl4r’s AI-powered analysis.

Kronos price forecasts, scored fundamentals & technicals, and a multi-horizon plan.

View the live AON price forecast →

AON has been derated ~15% from 52-week highs on a debt-funded $17B USI acquisition and a CFO transition, pushing the stock to $323 with RSI at 35 and trading below all key moving averages. Fundamentals remain high-quality (44.7% ROE, 22% net margins, $3.2B FCF) and a $6.5M insider cluster buy from a director plus 3pp jump in institutional ownership signal that smart money is stepping in at these levels. I rate this ACCUMULATE with medium conviction — the risk/reward has improved materially versus the prior optimistic call, but leverage is now elevated and near-term forecasts are muted.

ACCUMULATE
medium convictiongenerated 9/4/2026, 9:36:47 PM
Scores
Fundamentals
7.5
Technicals
4.0
Growth potential
6.5
Risk
6.0
Overall
6.5
Charts the model saw
Bear
$298.00
Base
$355.00
Bull
$385.00
over ~6 months
Investment plan
Short term · 1-4 weeks

1-4 week view: Start a partial position (1/3 to 1/2 of target size) at current $323, with a plan to add on either (a) a reclaim of $335 on volume, confirming the RSI-35 oversold bounce, or (b) a flush to the $308-315 zone that would represent capitulation near the 52-week low. Invalidation below $304 (52-week low breach) — that would signal the acquisition thesis is failing to find buyers. Insider cluster buy at ~$327 sets a soft floor of institutional interest.

Mid term · 1-6 months

1-6 month view: The setup rhymes with post-NFP: heavy debt, integration overhang, multiple compression, then re-rating as synergies materialize. Base case is a recovery to $355-365 as the market digests the deal and Q3 earnings (Oct 30) provide first update on integration plans. Expected return range: +10% to +15% base, -5% bear. What changes my mind: (1) Q3 earnings showing organic growth deceleration below 4%, (2) further debt downgrades from rating agencies, (3) any hint that USI synergies are being pushed out.

Long term · 1-3 years

1-3 year view: AON is a durable compounder in an oligopolistic industry with pricing power (Marsh, AON, WTW dominate). The combined USI+NFP middle-market platform should drive mid-single-digit organic growth plus 100-200bps of margin expansion once integration completes by 2028. Terminal P/E of 18-20x on ~$25 EPS suggests $450-500 over 3 years. Biggest structural risk: insurance broker consolidation has driven multiple compression across the industry, and if AON becomes financial-engineering-dependent rather than organic-growth-driven, the multiple could permanently derate.

Fundamentals

AON generates $17.58B TTM revenue with a 22.27% net margin and an outstanding 44.7% ROE, producing $3.19B in free cash flow against a $68.5B market cap (~4.7% FCF yield). Quarterly trends are noisy but healthy: Q2 2026 revenue of $4.25B with operating margin of 23.8% (down from Q1's 35.9% peak, which included seasonal reinsurance timing), and TTM sales growth of 4.36% is subdued but consistent with a mature broker. The balance sheet is the sore spot — $15.87B total debt against $9.6B equity gives D/E of 1.65, and the pending $17B USI deal will materially increase leverage (EV/EBITDA already 14.1x). That said, operating cash flow of $3.53B comfortably covers interest and the 1% dividend (17% payout ratio), and management has a track record of digesting the $13B NFP deal. Forward P/E of 15.6x is reasonable for a compounder of this quality, though PEG of 1.32 doesn't scream cheap.

Technicals

The setup is decidedly weak across timeframes. The 1h chart shows a violent breakdown from the $360 area in early September to $323.80, with price now sitting near the lows of the visible range. The 4h and daily charts confirm AON is in a clear downtrend from the ~$405 highs earlier this year, having lost the $340 support that held multiple times. RSI at 35.13 is approaching oversold but hasn't yet flipped; price sits -6.7% below SMA20, -8.5% below SMA50, and -4.2% below SMA200, with -15.5% drawdown from the 52-week high of $382.34. Perf Week -9.09% and Perf Month -10.44% reflect the acquisition-shock repricing. The model's forecasts are mixed — the 1h forecast band sits near current levels, the 4h band projects a bounce to ~$354, and the daily projects modest recovery to $344. However, model reliability is weak: 1d directional accuracy (73%) is below the naive baseline (75%), so discount the near-term bullish signal. Key support: $320/$308 (52-week low $304.59). Key resistance: $335 (broken support), then $355.

News read

The dominant story is the August 31 announcement of Aon's $17B all-cash acquisition of USI Insurance Services from KKR, funded via debt. USI brings ~$3B in annual revenue and $395M targeted synergies, extending AON's US middle-market footprint after the 2024 NFP deal. The market's response has been unambiguously negative — the stock has fallen ~$40 (~11%) since, reflecting concerns about deal size, integration risk on top of NFP, and further leverage. Evercore ISI maintained Outperform but cut its target from $436 to $423. Separately, CFO Edmund Reese is transitioning to a senior advisor role — a leadership change at a critical integration juncture that adds execution uncertainty. On the positive side, a director (Lester Knight) made a $6.55M cluster of open-market purchases on September 2 — a strong conviction signal from someone with full visibility, and institutional ownership has ticked up 3pp to 91.7%. Broader Marsh/WTW headlines suggest secular tailwinds in insurance broking (employer health costs +8.2% expected in 2027) remain intact.

Growth / roadmap
  • USI acquisition adds ~$3B annual revenue and targets $395M in cost synergies by year 3, extending US middle-market reach
  • Prior NFP integration ($13B, 2024) beginning to contribute margin uplift as cross-sell ramps in Risk Capital segment
  • Health Solutions tailwind: employer health costs projected +8.2% in 2027 per Marsh survey — drives brokerage commissions
  • AI-driven risk analytics initiatives supporting premium pricing in the core commercial risk segment
  • Institutional ownership +3pp to 91.7% in 45 days shows continued professional accumulation despite the drawdown
Risks
  • Debt/Equity of 1.65x will spike further post-USI close; leverage is now the primary balance sheet concern
  • CFO departure announced August 17 during a period of major integration — leadership transition risk is elevated
  • Prior call's base target ($376) has failed to print and current price is 14% below the initial thesis entry — momentum is broken
  • Two large acquisitions (NFP $13B + USI $17B) in ~2 years creates significant integration execution risk
  • Forward P/E 15.6x with only 4.4% sales growth means the market is paying for margin expansion that must actually materialize
  • Short-term forecast model has recently underperformed the naive baseline — near-term directional signal is unreliable

Get AI analysis on any stock

This is one of hundreds of Kronos AI reports — scored fundamentals & technicals, bull/base/bear price targets, a multi-horizon plan, and continuously-updated forecasts across the market. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord

⚠️ This AI-generated analysis is for informational purposes only and is not financial advice. Forecasts and scores are model outputs that can be wrong; markets involve substantial risk of loss. Do your own research.